Published in J Allergy Clin Immunol on February 01, 2002
Regulatory T cells in asthma. Immunity (2009) 2.00
Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol (2010) 1.84
Tregs and allergic disease. J Clin Invest (2004) 1.64
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci U S A (2008) 1.44
Regulatory T cells in many flavors control asthma. Mucosal Immunol (2010) 1.28
The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med (2012) 1.22
The atopic march: what's the evidence? Ann Allergy Asthma Immunol (2009) 1.21
Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med (2006) 1.13
Allergic rhinitis: evidence for impact on asthma. BMC Pulm Med (2006) 1.12
Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov (2009) 1.10
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. J Intern Med (2012) 1.08
Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics (2013) 1.07
Nonhuman primate models of asthma. J Exp Med (2005) 1.05
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol (2014) 1.05
Sub-lingual immunotherapy: world allergy organization position paper 2009. World Allergy Organ J (2009) 1.03
Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J (2015) 1.03
The National Institutes of Allergy and Infectious Diseases networks on asthma in inner-city children: an approach to improved care. J Allergy Clin Immunol (2010) 1.02
Immunomodulation of allergic disease. Annu Rev Med (2009) 1.02
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives. Vaccine (2011) 1.01
Safety of engineered allergen-specific immunotherapy vaccines. Curr Opin Allergy Clin Immunol (2012) 0.97
Improving the management of atopic disease. Arch Dis Child (2005) 0.93
Tolerizing allergic responses in the lung. Mucosal Immunol (2010) 0.88
Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses. Chest (2012) 0.88
Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI). Allergy Asthma Clin Immunol (2006) 0.87
Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children. Clin Exp Immunol (2010) 0.87
Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy (2012) 0.87
Time interval and the factors associated with the development of asthma in patients with allergic rhinitis. Lung (2009) 0.87
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy. Curr Treat Options Allergy (2014) 0.86
Intralymphatic immunotherapy. World Allergy Organ J (2015) 0.86
Clinical immunology review series: an approach to desensitization. Clin Exp Immunol (2010) 0.85
Incidence of asthma and mortality in a cohort of young adults: a 7-year prospective study. Respir Res (2005) 0.85
The role of allergen exposure and avoidance in asthma. Adolesc Med State Art Rev (2010) 0.85
Immunotherapy - Vaccines for allergic diseases. J Thorac Dis (2012) 0.83
Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitis. Am J Rhinol Allergy (2013) 0.83
Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study. Respir Res (2005) 0.83
Induction of tolerance via the sublingual route: mechanisms and applications. Clin Dev Immunol (2011) 0.83
Immunotherapy with allergen peptides. Allergy Asthma Clin Immunol (2007) 0.83
Safety aspects of subcutaneous immunotherapy with multiple allergens--a retrospective analysis on polysensitized patients. Eur Arch Otorhinolaryngol (2010) 0.82
Intermittent allergic rhinitis. CMAJ (2010) 0.82
Clinical and immunological changes of immunotherapy in patients with atopic dermatitis: randomized controlled trial. ISRN Allergy (2012) 0.81
Identification of critical amino acids in an immunodominant IgE epitope of Pen c 13, a major allergen from Penicillium citrinum. PLoS One (2012) 0.81
New routes for allergen immunotherapy. Hum Vaccin Immunother (2012) 0.81
Effects of systemic versus local administration of corticosteroids on mucosal tolerance. J Immunol (2011) 0.81
A systematic review of predictive models for asthma development in children. BMC Med Inform Decis Mak (2015) 0.80
Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany. Clin Transl Allergy (2015) 0.80
Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis. Allergy Asthma Clin Immunol (2015) 0.80
Immunotherapy for allergies and asthma: present and future. Curr Opin Pharmacol (2010) 0.79
Prevention strategies for asthma--secondary prevention. CMAJ (2005) 0.78
United airway disease: current perspectives. J Asthma Allergy (2016) 0.77
The effect of rush immunotherapy with house dust mite in the production of IL-5 and IFN-gamma from the peripheral blood T cells of asthmatic children. J Korean Med Sci (2009) 0.77
The perception of allergen-specific immunotherapy among pediatricians in the primary care setting. Clin Mol Allergy (2015) 0.77
Current immunological approaches for management of allergic rhinitis and bronchial asthma. Inflamm Res (2009) 0.77
Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy. J Immunol (2015) 0.77
Asthma and allergic rhinitis: Linked in treatment and outcomes. Ann Thorac Med (2010) 0.77
Evaluation on the immunotherapy efficacies of synthetic peptide vaccines in asthmatic mice with group I and II allergens from Dermatophagoides pteronyssinus. Int J Clin Exp Med (2015) 0.77
Immunotherapy reduces allergen-mediated CD66b expression and myeloperoxidase levels on human neutrophils from allergic patients. PLoS One (2014) 0.77
Asthma in patients with Japanese cedar pollinosis. World Allergy Organ J (2012) 0.77
Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children. Clinicoecon Outcomes Res (2014) 0.76
Specific immunotherapy in grass pollen allergy. Hum Vaccin Immunother (2012) 0.76
Is The Allergen Really Needed in Allergy Immunotherapy? Curr Treat Options Allergy (2015) 0.76
Nasobronchial interaction. World J Clin Cases (2015) 0.76
Can immunotherapy prevent progression to asthma in allergic individuals? J Allergy Clin Immunol (2002) 0.76
[Allergen-specific Immunotherapy for children and adolescents - a review on available products in Austria]. Wien Klin Wochenschr (2009) 0.76
The PAT study's methods, asthma classification, and results are questionable. J Allergy Clin Immunol (2002) 0.75
Allergic rhinitis: the "Ghost Diagnosis" in patients with asthma. Asthma Res Pract (2015) 0.75
Effects of nasal corticosteroids on boosts of systemic allergen-specific IgE production induced by nasal allergen exposure. PLoS One (2015) 0.75
Allergen-specific immunotherapy in pediatric allergic asthma. Asia Pac Allergy (2016) 0.75
Clinical Immunology Review Series: An approach to the patient with allergy in childhood. Clin Exp Immunol (2009) 0.75
Allergen immunotherapy in asthma; what is new? Asthma Res Pract (2015) 0.75
Treatment of seasonal allergic rhinitis: desensitisation for hay fever works. BMJ (2003) 0.75
Construction of the recombinant vaccine based on T-cell epitope encoding Der p1 and evaluation on its specific immunotherapy efficacy. Int J Clin Exp Med (2015) 0.75
Role of immunotherapy in the treatment of allergic asthma. World J Clin Cases (2014) 0.75
Early detection of allergic diseases in otorhinolaryngology. GMS Curr Top Otorhinolaryngol Head Neck Surg (2010) 0.75
Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report. Ital J Pediatr (2017) 0.75
Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet. Ann Thorac Med (2010) 0.75
Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment. Allergo J Int (2016) 0.75
Joint incidence of asthma and rhinitis in macedonia. Open Respir Med J (2015) 0.75
Transcutaneous Peptide Immunotherapy of Japanese Cedar Pollinosis Using Solid-in-Oil Nanodispersion Technology. AAPS PharmSciTech (2015) 0.75
Actual therapeutic management of allergic and hyperreactive nasal disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg (2004) 0.75
Allergic sensitization to perennial allergens in adults and children sensitized to Japanese cedar or Japanese cypress pollen in Japan. Int J Otolaryngol (2014) 0.75
Critical appraisal of Timothy grass pollen extract GRAZAX(®) in the management of allergic rhinitis. Drug Des Devel Ther (2015) 0.75
Anti-inflammatory effects of pre-seasonal Th1-adjuvant vaccine to Parietaria judaica in asthmatics. J Asthma Allergy (2011) 0.75
Update on allergy immunotherapy. Allergy Asthma Clin Immunol (2005) 0.75
Clinical utility and patient adherence with ebastine for allergic rhinitis. Patient Prefer Adherence (2010) 0.75
Sublingual Immunotherapy: A Useful Tool for the Allergist in Private Practice. Biomed Res Int (2016) 0.75
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients. Clin Transl Allergy (2013) 0.75
Polysensitisation to pollen due to profilin and calcium-binding protein: distribution of IgE antibodies to marker allergens in grass and birch pollen allergic rhinitis patients in southern Germany. Eur Arch Otorhinolaryngol (2013) 0.75
Clinical practice: Allergen-specific immunotherapy in children: facts and FAQs. Eur J Pediatr (2010) 0.75
Editorial overview: novel concepts in the pathogenesis and therapy of allergy and asthma. Springer Semin Immunopathol (2003) 0.75
[Costs of allergic diseases and saving potential by allergen-specific immunotherapy : A personal assessment]. HNO (2017) 0.75
Current and future management of the young child with early onset wheezing. Curr Opin Allergy Clin Immunol (2017) 0.75
Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract. Curr Allergy Asthma Rep (2017) 0.75
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol (2015) 2.82
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet (2006) 2.81
The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol (2004) 2.69
Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics (2005) 2.56
Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol (2010) 2.50
Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. Dtsch Arztebl Int (2014) 2.47
Early identification of atopy in the prediction of persistent asthma in children. Lancet (2008) 2.27
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol (2006) 2.09
Primary ciliary dyskinesia associated with normal axoneme ultrastructure is caused by DNAH11 mutations. Hum Mutat (2008) 2.03
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Maternal smoking in pregnancy and asthma in preschool children: a pooled analysis of eight birth cohorts. Am J Respir Crit Care Med (2012) 1.98
Can family history and cord blood IgE predict sensitization and allergic diseases up to adulthood? Pediatr Allergy Immunol (2014) 1.98
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J (2006) 1.94
[Allergy tests]. Ugeskr Laeger (2004) 1.93
A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet (2009) 1.91
Clinical course of cow's milk protein allergy/intolerance and atopic diseases in childhood. Pediatr Allergy Immunol (2002) 1.80
Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol (2004) 1.79
Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics (2009) 1.76
Acupuncture in patients with seasonal allergic rhinitis: a randomized trial. Ann Intern Med (2013) 1.76
Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol (2012) 1.71
Body mass index trajectory classes and incident asthma in childhood: results from 8 European Birth Cohorts--a Global Allergy and Asthma European Network initiative. J Allergy Clin Immunol (2013) 1.71
Effect of mattress and pillow encasings on children with asthma and house dust mite allergy. J Allergy Clin Immunol (2003) 1.65
Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper. World Allergy Organ J (2012) 1.60
1 alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res (2002) 1.58
Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma. Am J Respir Crit Care Med (2005) 1.58
Requirements for physician competencies in allergy: key clinical competencies appropriate for the care of patients with allergic or immunologic diseases: a position statement of the world allergy organization. World Allergy Organ J (2008) 1.57
Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents. Pediatr Allergy Immunol (2010) 1.52
Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics (2008) 1.51
Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF. Cytokine (2008) 1.46
What is an Allergist?: Reconciled Document Incorporating Member Society Comments, September 3, 2007. World Allergy Organ J (2008) 1.43
Evaluation of allergen exposure. J Allergy Clin Immunol (2005) 1.43
Adrenaline autoinjectors in food allergy: in for a cent, in for a euro? Pediatr Allergy Immunol (2012) 1.39
Does pet ownership in infancy lead to asthma or allergy at school age? Pooled analysis of individual participant data from 11 European birth cohorts. PLoS One (2012) 1.39
[Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis]. Ugeskr Laeger (2012) 1.38
Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council. Int Arch Allergy Immunol (2005) 1.36
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol (2002) 1.34
Life-threatening vallecular cyst in a 3-month-old infant: case report and literature review. Clin Pediatr (Phila) (2004) 1.34
Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol (2008) 1.33
The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument. Qual Life Res (2003) 1.31
Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros (2004) 1.29
ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol (2006) 1.26
Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Respir Crit Care Med (2003) 1.24
Use of complementary/alternative medicine among paediatric patients. Eur J Pediatr (2003) 1.24
Prenatal stress enhances susceptibility of murine adult offspring toward airway inflammation. J Immunol (2006) 1.24
Dietary prevention of allergic diseases in infants and small children. Pediatr Allergy Immunol (2008) 1.24
Asthma out of control? A structured review of recent patient surveys. BMC Pulm Med (2006) 1.24
Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. PLoS Biol (2007) 1.21
Associations between total serum IgE levels and the 6 potentially functional variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J Allergy Clin Immunol (2003) 1.20
An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. J Allergy Clin Immunol (2009) 1.19
Dietary prevention of allergic diseases in infants and small children. Part III: Critical review of published peer-reviewed observational and interventional studies and final recommendations. Pediatr Allergy Immunol (2004) 1.15
Allergic rhinitis as a predictor for wheezing onset in school-aged children. J Allergy Clin Immunol (2010) 1.14
Clonal expansion of CD8+ effector T cells in childhood tuberculosis. J Immunol (2007) 1.10
Rush oral immunotherapy in children with persistent cow's milk allergy. J Allergy Clin Immunol (2008) 1.10
Interactions between genes and environmental factors in asthma and atopy: new developments. Respir Res (2001) 1.09
Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. Acta Derm Venereol (2006) 1.09
Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr Allergy Immunol (2010) 1.07
The development of childhood asthma: lessons from the German Multicentre Allergy Study (MAS). Paediatr Respir Rev (2002) 1.07
Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol (2009) 1.06
Dietary prevention of allergic diseases in infants and small children. Part II. Evaluation of methods in allergy prevention studies and sensitization markers. Definitions and diagnostic criteria of allergic diseases. Pediatr Allergy Immunol (2004) 1.06
The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations. Respir Res (2006) 1.04
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy (2012) 1.04
Provoking allergens and treatment of anaphylaxis in children and adolescents--data from the anaphylaxis registry of German-speaking countries. Pediatr Allergy Immunol (2011) 1.04
Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol (2010) 1.03
Repeated validation of parental self-reported smoking during pregnancy and infancy: a prospective cohort study of infants at high risk for allergy development. Paediatr Perinat Epidemiol (2004) 1.03
Human milk--derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res (2004) 1.02
How pre- and postnatal risk factors modify the effect of rapid weight gain in infancy and early childhood on subsequent fat mass development: results from the Multicenter Allergy Study 90. Am J Clin Nutr (2008) 1.02
Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol (2002) 1.01
Can the use of HEPA cleaners in homes of asthmatic children and adolescents sensitized to cat and dog allergens decrease bronchial hyperresponsiveness and allergen contents in solid dust? Int Arch Allergy Immunol (2008) 1.01
The association between early sensitization patterns and subsequent allergic disease. The DARC birth cohort study. Pediatr Allergy Immunol (2009) 1.00
A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. J Allergy Clin Immunol (2007) 1.00
Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol (2002) 0.99
Minimal inflammation, acute phase response and avoidance of misclassification of vitamin A and iron status in infants--importance of a high-sensitivity C-reactive protein (CRP) assay. Int J Vitam Nutr Res (2003) 0.99
Development of atopic dermatitis in the DARC birth cohort. Pediatr Allergy Immunol (2009) 0.99